The ongoing transformation of healthcare delivery by artificial intelligence may feel sudden, but historians of the field will recognize it as the culmination of a journey that began more than half a century ago. From the early rule-based diagnostic systems of the 1970s — most notably MYCIN, Stanford's experimental program for identifying bacterial infections — to the neural network renaissance of the 2010s, medicine has long been one of AI's most ambitious frontiers.
What is different today is scale and integration. Where earlier systems operated in controlled research environments, modern AI tools are embedding themselves directly into clinical workflows — triaging patients, flagging anomalous imaging results, predicting sepsis onset, and even drafting physician notes. The disruption being felt across hospitals and private practices is not the arrival of something alien, but rather the maturation of ideas that pioneers like Edward Shortliffe and researchers at institutions like MIT and Johns Hopkins were sketching out on whiteboards decades ago.
The friction this creates is also familiar. Debates about liability, physician autonomy, algorithmic bias, and the erosion of the patient-doctor relationship echo concerns raised every time a transformative technology — from the stethoscope to electronic health records — entered the exam room. Medical culture has historically been cautious, and for good reason: the stakes of error are uniquely high.
What the current wave demands, as it has in every prior cycle, is not a choice between human judgment and machine intelligence, but a deliberate framework for combining both. Regulatory bodies, medical schools, and hospital systems are now racing to build that framework in real time. How well they succeed will likely define the character of medicine for the next generation — and give future historians yet another milestone to mark in AI's long, unfinished story.